Outlook Therapeutics (OTLK) Shareholder's Equity (QoQ) (2016 - 2026)
Outlook Therapeutics (OTLK) Shareholder's Equity (QoQ) (2016 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
| 10 |
Outlook Therapeutics |
51.56 Mn |
43.81 Mn |
-21,888.00 |
| Date | Value |
|---|
| Mar 31, 2026 |
24.79% |
| Dec 31, 2025 |
-19.76% |
| Sep 30, 2025 |
13.45% |
| Jun 30, 2025 |
-14.56% |
| Mar 31, 2025 |
35.45% |
| Dec 31, 2024 |
31.18% |
| Sep 30, 2024 |
12.66% |
| Jun 30, 2024 |
37.67% |
| Mar 31, 2024 |
-451.43% |
| Dec 31, 2023 |
-68.61% |
| Sep 30, 2023 |
-162.37% |
| Jun 30, 2023 |
-152.47% |
| Mar 31, 2023 |
-33.45% |
| Dec 31, 2022 |
80.38% |
| Sep 30, 2022 |
-56.50% |
| Jun 30, 2022 |
-44.16% |
| Mar 31, 2022 |
-26.34% |
| Dec 31, 2021 |
959.66% |
| Sep 30, 2021 |
-63.86% |
| Jun 30, 2021 |
-38.26% |
